Table B1.

Estimated Coefficients from Risk Adjustment Regressions

Variables	Concurrent Coefficient	Prospective Coefficient
Male, age 21–24	0.18	0.25
Male, age 25–29	0.22	0.28
Male, age 30–24	0.25	0.32
Male, age 35–39	0.28	0.37
Male, age 40–44	0.32	0.44
Male, age 45–49	0.38	0.57
Male, age 50–54	0.45	0.72
Male, age 55–59	0.52	0.91
Male, age > 60	0.59	1.11
Female, age 21–24	0.31	0.57
Female, age 25–29	0.38	0.78
Female, age 30–24	0.45	0.79
Female, age 35–39	0.49	0.70
Female, age 40–44	0.53	0.69
Female, age 45–49	0.56	0.76
Female, age 50–54	0.60	0.84
Female, age 55–59	0.62	0.93
Female, age > 60	0.66	1.06
HIV/AIDS	0.42	0.63
Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock	11.68	2.51
Central Nervous System Infections, Except Viral Meningitis	5.11	1.16
Viral or Unspecified Meningitis	2.45	0.68
Opportunistic Infections	3.61	1.74
Metastatic Cancer	14.95	11.35
Lung, Brain, and Other Severe Cancers, Including Pediatric Acute Lymphoid Leukemia	6.25	5.28
Non-Hodgkin’s Lymphomas and Other Cancers and Tumors	4.07	3.43
Colorectal, Breast (Age < 50), Kidney, and Other Cancers	3.91	2.70
Breast (Age 50+) and Prostate Cancer, Benign/Uncertain Brain Tumors, and Other Cancers and
Tumors	2.28	1.31
Thyroid Cancer, Melanoma, Neurofibromatosis, and Other Cancers and Tumors	1.11	0.71
Pancreas Transplant Status/Complications	4.99	3.81
Protein-Calorie Malnutrition	8.59	2.23
Liver Transplant Status/Complications	10.55	3.40
End-Stage Liver Disease	3.52	5.49
Cirrhosis of Liver	1.28	2.37
Chronic Hepatitis	0.69	0.67
Acute Liver Failure/Disease, Including Neonatal Hepatitis	2.04	1.03
Intestine Transplant Status/Complications	28.22	20.70
Peritonitis/Gastrointestinal Perforation/Necrotizing Enterocolitis	13.36	2.26
Intestinal Obstruction	5.03	1.63
Chronic Pancreatitis	4.23	3.09
Acute Pancreatitis/Other Pancreatic Disorders and Intestinal Malabsorption	2.41	1.27
Inflammatory Bowel Disease	1.39	1.44
Rheumatoid Arthritis and Specified Autoimmune Disorders	1.34	1.48
Systemic Lupus Erythematosus and Other Autoimmune Disorders	0.68	0.88
Cleft Lip/Cleft Palate	1.44	1.11
Hemophilia	28.28	30.83
Coagulation Defects and Other Specified Hematological Disorders	2.00	1.04
Schizophrenia	1.36	1.03
Major Depressive and Bipolar Disorders	0.90	0.86
Reactive and Unspecified Psychosis, Delusional Disorders	1.94	1.06
Personality Disorders	0.67	0.67
Anorexia/Bulimia Nervosa	1.40	1.17
Prader-Willi, Patau, Edwards, and Autosomal Deletion Syndromes	2.86	1.14
Down Syndrome, Fragile X, Other Chromosomal Anomalies, and Congenital Malformation Syndromes	1.16	0.74
Autistic Disorder	0.28	0.45
Pervasive Developmental Disorders, Except Autistic Disorder	0.44	0.10
Spinal Cord Disorders/Injuries	4.28	1.65
Amyotrophic Lateral Sclerosis and Other Anterior Horn Cell Disease	2.08	3.42
Quadriplegic Cerebral Palsy	1.07	2.97
Cerebral Palsy, Except Quadriplegic	0.23	0.84
Spina Bifida and Other Brain/Spinal/Nervous System Congenital Anomalies	0.96	1.03
Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome/Inflammatory and Toxic
Neuropathy	2.97	2.47
Multiple Sclerosis	1.39	1.55
Seizure Disorders and Convulsions	6.63	1.13
Hydrocephalus	5.69	1.58
Non-Traumatic Coma, Brain Compression/Anoxic Damage	9.16	1.26
Respirator Dependence/Tracheostomy Status	25.91	4.06
Congestive Heart Failure	2.42	2.02
Acute Myocardial Infarction	8.29	1.06
Unstable Angina and Other Acute Ischemic Heart Disease	4.38	1.17
Heart Infection/Inflammation, Except Rheumatic	4.03	1.21
Specified Heart Arrhythmias	2.23	1.15
Intracranial Hemorrhage	6.50	1.15
Ischemic or Unspecified Stroke	2.98	1.06
Cerebral Aneurysm and Arteriovenous Malformation	3.67	1.27
Hemiplegia/Hemiparesis	4.17	1.75
Monoplegia, Other Paralytic Syndromes	2.55	1.29
Atherosclerosis of the Extremities with Ulceration or Gangrene	6.91	4.05
Vascular Disease with Complications	4.85	1.61
Pulmonary Embolism and Deep Vein Thrombosis	8.29	1.44
Lung Transplant Status/Complications	18.13	13.17
Cystic Fibrosis	2.59	4.27
Fibrosis of Lung and Other Lung Disorders	1.72	1.15
Aspiration and Specified Bacterial Pneumonias and Other Severe Lung Infections	3.39	1.06
Kidney Transplant Status	6.38	4.85
End Stage Renal Disease	24.95	29.00
Chronic Ulcer of Skin, Except Pressure	1.56	1.79
Hip Fractures and Pathological Vertebral or Humerus Fractures	6.08	2.49
Pathological Fractures, Except of Vertebrae, Hip, or Humerus	1.12	0.67
Stem Cell, Including Bone Marrow, Transplant Status/Complications	17.78	3.71
Artificial Openings for Feeding or Elimination	7.04	2.27
Amputation Status, Lower Limb/Amputation Complications	4.13	2.81
Group 01	0.58	0.72
Group 02A	1.55	1.13
Group 03	4.39	1.82
Group 04	2.67	1.55
Group 06	7.70	5.40
Group 07	5.08	3.83
Group 08	3.45	3.24
Group 09	2.49	1.78
Group 10	8.45	4.95
Group 11	6.77	4.43
Group 12	1.09	1.23
Group 13	12.02	1.72
Group 14	21.79	9.27
Group 15	0.68	0.66
Group 16	1.39	4.75
Group 17	0.95	1.20
Group 18	2.57	−0.14
Interaction Group M	−4.98	1.00
Interaction Group H	−3.00	1.31
Severe Illness Indicator	−6.05	−0.36
Severe X Opportunistic Infections	14.00	1.31
Severe X Metastatic Cancer	7.40	0.73
Severe X Lung, Brain, and Other Severe Cancers, Including Pediatric Acute Lymphoid Leukemia	6.44	0.33
Severe X Non-Hodgkin’s Lymphomas and Other Cancers and Tumors	7.55	1.16
Severe X Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome/Inflammatory and
Toxic Neuropathy	7.13	0.42
Severe X Heart Infection/Inflammation, Except Rheumatic	7.94	0.53
Severe X Intracranial Hemorrhage	8.38	−1.78
Severe X Group 06	7.10	2.95
Severe X Group 08	5.28	1.16
Severe X End-Stage Liver Disease	3.33	0.03
Severe X Acute Liver Failure/Disease, Including Neonatal Hepatitis	6.47	−2.28
Severe X Atherosclerosis of the Extremities with Ulceration or Gangrene	7.51	2.78
Severe X Vascular Disease with Complications	7.56	−2.01
Severe X Aspiration and Specified Bacterial Pneumonias and Other Severe Lung Infections	8.44	−1.47
Severe X Artificial Openings for Feeding or Elimination	9.21	−0.59
Severe X Group 03	8.72	0.89